Turn Biotechnologies

Aging has been called the emperor of all maladies. Turn Bios goal is to address multiple aging-related indications using a single powerful reprogramming therapy that turns old cells young again, aiding in the rejuvenation of an aged human body. In 2013, a paper in Cell (The hallmarks of aging, Lopez-Otin et al.,) proposed nine key Hallmarks of Aging that are causes of the general phenotype we refer to as aging. Our team recognized that it would be necessary to turn back the clock on each of these hallmarks and so set out to develop the technology to do just that....

Cell reprogramming,biotechnology,cellular programming,scnt,mrna,aging,dermatology,ophthalmology,osteoarthritis,research and development,and r&d

Turn biotechnologies operates in the Biotechnology industry.

Turn biotechnologies's revenue is 11m - 100m

Turn biotechnologies has 11 - 50 employees.